Chichareon S, Herrero R, Muñoz N, Bosch F X, Jacobs M V, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer C J, Walboomers J M
Department of Obstetrics-Gynecology, Faculty of Medicine, Prince of Songkla University, Hat-Yai, Thailand.
J Natl Cancer Inst. 1998 Jan 7;90(1):50-7. doi: 10.1093/jnci/90.1.50.
Human papillomaviruses (HPV) types 16 and 18 are clearly involved in the etiology of cervical cancer, but the evidence for the carcinogenicity of other HPV types is limited. Cofactors involved in the progression from infection with HPV to high-grade precursors and cancer have not been clearly defined by the results of previous studies.
We conducted a hospital-based, case-control study of invasive cervical cancer to investigate risk in relation to HPV infection and its epidemiologic cofactors in Hat-Yai, Thailand. A total of 338 patients with squamous cell carcinoma, 39 patients with adenocarcinoma/adenosquamous carcinoma, and 261 control subjects were included in the study and were interviewed to obtain information with regard to cervical cancer risk factors. HPV DNA presence in cervical exfoliated cells or frozen biopsy specimens was determined by a polymerase chain reaction assay.
HPV DNA was detected in 95% of patients with squamous cell carcinoma, 90% of those with adenocarcinoma/adenosquamous carcinoma, and 16% of control subjects. For patients with squamous cell carcinoma, the most common types of HPV found were type 16 (60% of the positives), type 18 (18%), type 58 (3%), type 52 (3%), and type 31 (2%). For patients with adenocarcinoma/adenosquamous carcinoma, the most common HPV types found were type 18 (60% of the positives), type 16 (37%), and type 45 (3%). The risk factors that remained associated with risk of both histologic types after adjustment for HPV and their mutual confounding effects were limited education, increasing number of sexual partners, history of venereal diseases, and interval since last Pap smear (i.e., cytologic) test. Among patients with squamous cell carcinoma, some association with smoking was also observed.
New preventive strategies for cervical cancer will require the consideration of multiple HPV types.
16型和18型人乳头瘤病毒(HPV)显然与宫颈癌的病因有关,但其他HPV型别致癌性的证据有限。先前研究结果尚未明确界定从HPV感染发展为高级别癌前病变和癌症过程中涉及的协同因素。
我们在泰国合艾开展了一项基于医院的浸润性宫颈癌病例对照研究,以调查HPV感染及其流行病学协同因素相关的风险。共有338例鳞状细胞癌患者、39例腺癌/腺鳞癌患者和261例对照纳入研究,并接受访谈以获取有关宫颈癌危险因素的信息。通过聚合酶链反应检测法测定宫颈脱落细胞或冷冻活检标本中HPV DNA的存在情况。
95%的鳞状细胞癌患者、90%的腺癌/腺鳞癌患者和16%的对照者检测到HPV DNA。对于鳞状细胞癌患者,最常见的HPV型别为16型(占阳性病例的60%)、18型(18%)、58型(3%)、52型(3%)和31型(2%)。对于腺癌/腺鳞癌患者,最常见的HPV型别为18型(占阳性病例的60%)、16型(37%)和45型(3%)。在对HPV及其相互混杂效应进行校正后,仍与两种组织学类型风险相关的危险因素包括教育程度低、性伴侣数量增加、性病病史以及自上次巴氏涂片(即细胞学)检查以来的间隔时间。在鳞状细胞癌患者中,还观察到与吸烟存在一定关联。
宫颈癌新的预防策略需要考虑多种HPV型别。